Results 111 to 120 of about 1,845,886 (394)

Cloning and expression analysis of SPL8 homolog from pak choi (Brassica rapa subsp. chinensis)

Biotechnology & Biotechnological Equipment, 2017
SQUAMOSA PROMOTER-BINDING PROTEIN-LIKE (SPL) transcription factor genes are functionally diverse; they control a number of fundamental aspects of plant growth and development, including vegetative phase change, flowering time, branching and leaf ...
Jing Zhang, A-Min Ping, Xue-Ting Wang, Gai-Zhen Li, Zhu-Jun Zhu, Mei-Lan Li, Guo-Ming Xing, Lei-Ping Hou   +7 more
doaj   +1 more source

Cloning, Sequencing, and Expression of the Gene Encoding a Family 9 Cellulase from Bacillus licheniformis F11 in Escherichia coli and Bacillus megaterium, and Characterization of the Recombinant Enzymes

Microbiology Indonesia, 2015
A gene encoding cellulase belonging to the glycosyl hydrolase family 9 along with its native promoter was isolated from Bacillus licheniformis F11, cloned in Escherichia coli DH5 α and subcloned by transconjugation to Bacillus megaterium MS941 ...
IS HELIANTI, MARIA ULFAH, NIKNIK NURHAYATI, LLINA MULYAWATI   +3 more
doaj   +1 more source

The Identity of Clones

The Journal of Medicine and Philosophy, 1999
A common concern with respect to cloning is based on the belief that cloning produces identical individuals. This is a fundamental misunderstanding of what type of identity-relation cloning involves. The concept "identity" is ambiguous, and the statement that cloning produces "identical" individuals is not meaningful unless the notion of identity is ...
openaire   +4 more sources

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Economical Phase-Covariant Cloning of Qudits

, 2005
We derive the optimal N to M phase-covariant quantum cloning for equatorial states in dimension d with M=kd+N, k integer. The cloning maps are optimal for both global and single-qudit fidelity.
Buscemi, Francesco, D'Ariano, Giacomo Mauro, Macchiavello, Chiara   +2 more
core   +1 more source

Toward therapeutic cloning and regenerative biology research forum: To clone or not to clone [PDF]

Reproductive Biology and Endocrinology, 2003
Creating exact copies (clones) of an individual has long been a made-to-believe story in various cultures throughout mankind history. However, the report of successfully creating a genetic clone of an adult animal from a differentiated somatic cell completely shocked the world.
openaire   +4 more sources

Gateway Recombinational Cloning.

Cold Spring Harbor Protocols, 2018
The Gateway recombinatorial cloning system was developed for cloning multiple DNA fragments in parallel (e.g., in 96-well formats) in a standardized manner using the same enzymes.
John Reece-Hoyes, Albertha J. M. Walhout
semanticscholar   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

THE PLACE OF STOCKS IN THE PROPAGATION OF CLONAL VARIETIES OF APPLES [PDF]

, 1923
Karl Sax, John W. Gowen
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source